Home NDC 70710-2159 Riociguat
Product NDC 70710-2159
11-digit product format 707102159
Labeler code 70710
Product ID 70710-2159_b7d9755e-0ea7-405a-90b5-95ae93e9c3b3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Riociguat
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Zydus Pharmaceuticals USA Inc
Application ANDA211135
Marketing category ANDA
Marketing start 2026-09-18
Substance RIOCIGUAT
Active strength 2 mg/1
Pharmacologic classes Guanylate Cyclase Stimulators [MoA], Soluble Guanylate Cyclase Stimulator [EPC]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 5 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A211135-001 RIOCIGUAT RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 A211135-002 RIOCIGUAT RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 A211135-003 RIOCIGUAT RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 A211135-004 RIOCIGUAT RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 A211135-005 RIOCIGUAT RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 5 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 155 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-11-14 07:37:17 2026-10 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 d4dbc9d85df4…2026-10-15 13:18:30 2026-09 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 c2088c7a36db…2026-10-15 13:18:30 2026-09 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 c2088c7a36db…2026-09-14 22:38:34 2026-08 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 84e616aacf4f…2026-09-14 22:38:34 2026-08 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 84e616aacf4f…2026-08-18 06:07:40 2026-07 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211135-001 RIOCIGUAT 0.5MG TABLET / ORAL AB 2022-09-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211135-002 RIOCIGUAT 1MG TABLET / ORAL AB 2022-09-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211135-003 RIOCIGUAT 1.5MG TABLET / ORAL AB 2022-09-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211135-004 RIOCIGUAT 2MG TABLET / ORAL AB 2022-09-01 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A211135-005 RIOCIGUAT 2.5MG TABLET / ORAL AB 2022-09-01 fd3edfee7708…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 4 · 155 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Riociguat
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength RIOCIGUAT 2 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination RU3FE2Y4XI Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 5 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1439821 Internal RxNorm lookup 1439823 Internal RxNorm lookup 1439831 Internal RxNorm lookup 1439833 Internal RxNorm lookup 1439837 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 70710-2159-8 70710215908 9 TABLET, FILM COATED in 1 BOTTLE (70710-2159-8) 2026-09-18 No No Current 70710-2159-9 70710215909 90 TABLET, FILM COATED in 1 BOTTLE (70710-2159-9) 2026-09-18 No No Current